Introduction Approximately 4–6% of patients treated with oral anticoagulants (OAC) will suffer from major hemorrhage or be in need of urgent surgery necessitating anticoagulant reversal therapy. Several new oral anticoagulants and reversal agents have been introduced that make it difficult for physicians to stay updated on the current evidence of reversal management. This study aims to review the recent literature on oral anticoagulation reversal therapy and to present the current evidence in an easily approachable manner. Materials and methods A systematic literature search was conducted using PubMed and EMBASE to identify the latest publications on both vitamin K antagonist (VKA) and direct oral anticoagulant (DOAC) reversal strategies. A...
Anticoagulation is the cornerstone of prevention and treatment of venous thromboembolism (VTE) and s...
Non-vitamin K antagonist oral anticoagulants (NOACs) include thrombin inhibitor dabigatran and coagu...
Anticoagulation is the cornerstone of prevention and treatment of venous thromboembolism (VTE) and s...
Oral anticoagulants (OA) are effective drugs for treating and preventing the formation of blood clot...
Oral anticoagulants (OA) are effective drugs for treating and preventing the formation of blood clot...
Oral anticoagulants (OA) are effective drugs for treating and preventing the formation of blood clot...
Oral anticoagulants (OA) are effective drugs for treating and preventing the formation of blood clot...
Anticoagulation is a necessary component of modern healthcare and is used to treat thromboembolic co...
In recent years, anticoagulant and antiplatelet use have increased over the past years for the preve...
Oral anticoagulants are commonly prescribed for the prevention and treatment of thromboembolic disor...
The direct oral anticoagulants (DOACs), or non-vitamin K antagonist oral anticoagulants (NOACs), inc...
Background and objectives: Oral anticoagulants prevent thromboembolic events but expose patients to ...
Anticoagulation is the cornerstone of prevention and treatment of venous thromboembolism (VTE) and s...
Anticoagulation is the cornerstone of prevention and treatment of venous thromboembolism (VTE) and s...
Anticoagulation is the cornerstone of prevention and treatment of venous thromboembolism (VTE) and s...
Anticoagulation is the cornerstone of prevention and treatment of venous thromboembolism (VTE) and s...
Non-vitamin K antagonist oral anticoagulants (NOACs) include thrombin inhibitor dabigatran and coagu...
Anticoagulation is the cornerstone of prevention and treatment of venous thromboembolism (VTE) and s...
Oral anticoagulants (OA) are effective drugs for treating and preventing the formation of blood clot...
Oral anticoagulants (OA) are effective drugs for treating and preventing the formation of blood clot...
Oral anticoagulants (OA) are effective drugs for treating and preventing the formation of blood clot...
Oral anticoagulants (OA) are effective drugs for treating and preventing the formation of blood clot...
Anticoagulation is a necessary component of modern healthcare and is used to treat thromboembolic co...
In recent years, anticoagulant and antiplatelet use have increased over the past years for the preve...
Oral anticoagulants are commonly prescribed for the prevention and treatment of thromboembolic disor...
The direct oral anticoagulants (DOACs), or non-vitamin K antagonist oral anticoagulants (NOACs), inc...
Background and objectives: Oral anticoagulants prevent thromboembolic events but expose patients to ...
Anticoagulation is the cornerstone of prevention and treatment of venous thromboembolism (VTE) and s...
Anticoagulation is the cornerstone of prevention and treatment of venous thromboembolism (VTE) and s...
Anticoagulation is the cornerstone of prevention and treatment of venous thromboembolism (VTE) and s...
Anticoagulation is the cornerstone of prevention and treatment of venous thromboembolism (VTE) and s...
Non-vitamin K antagonist oral anticoagulants (NOACs) include thrombin inhibitor dabigatran and coagu...
Anticoagulation is the cornerstone of prevention and treatment of venous thromboembolism (VTE) and s...